Literature DB >> 25525784

Microbial bile acid metabolic clusters: the bouncers at the bar.

Joseph A Sorg1.   

Abstract

Colonization resistance refers to the ability of the colonic microbiota to prevent invasion by pathogens including Clostridium difficile. In a recent article, Buffie et al. (2014) have demonstrated that a single metabolic cluster present in the normal, colonic microflora is responsible for preventing C. difficile invasion of healthy hosts.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25525784      PMCID： PMC4977530          DOI： 10.1016/j.chom.2014.10.015

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  9 in total

1.  A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.

Authors:  Gerald W Tannock; Karen Munro; Corinda Taylor; Blair Lawley; Wayne Young; Brendan Byrne; Judy Emery; Thomas Louie
Journal:  Microbiology (Reading)       Date:  2010-08-19       Impact factor: 2.777

Review 2.  Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer.

Authors:  Karl Weiss
Journal:  Int J Antimicrob Agents       Date:  2008-09-18       Impact factor: 5.283

Review 3.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

4.  Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination.

Authors:  K H Wilson
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

Review 5.  Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs.

Authors:  Mark J Koenigsknecht; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

6.  Bile salts and glycine as cogerminants for Clostridium difficile spores.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2008-02-01       Impact factor: 3.490

7.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.

Authors:  Casey M Theriot; Mark J Koenigsknecht; Paul E Carlson; Gabrielle E Hatton; Adam M Nelson; Bo Li; Gary B Huffnagle; Jun Z Li; Vincent B Young
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

8.  Metabolism of bile salts in mice influences spore germination in Clostridium difficile.

Authors:  Jennifer L Giel; Joseph A Sorg; Abraham L Sonenshein; Jun Zhu
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

9.  Muricholic acids inhibit Clostridium difficile spore germination and growth.

Authors:  Michael B Francis; Charlotte A Allen; Joseph A Sorg
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240
  9 in total
  8 in total

Review 1.  Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.

Authors:  Jenessa A Winston; Casey M Theriot
Journal:  Anaerobe       Date:  2016-05-07       Impact factor: 3.331

Review 2.  Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

3.  Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.

Authors:  Senu Apewokin; Jeannette Y Lee; Julia A Goodwin; Kent D McKelvey; Owen W Stephens; Daohong Zhou; Elizabeth Ann Coleman
Journal:  Support Care Cancer       Date:  2018-03-28       Impact factor: 3.603

4.  Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.

Authors:  J R Allegretti; S Kearney; N Li; E Bogart; K Bullock; G K Gerber; L Bry; C B Clish; E Alm; J R Korzenik
Journal:  Aliment Pharmacol Ther       Date:  2016-04-18       Impact factor: 8.171

5.  Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract.

Authors:  Mark J Koenigsknecht; Casey M Theriot; Ingrid L Bergin; Cassie A Schumacher; Patrick D Schloss; Vincent B Young
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

6.  The Ser/Thr Kinase PrkC Participates in Cell Wall Homeostasis and Antimicrobial Resistance in Clostridium difficile.

Authors:  Elodie Cuenot; Transito Garcia-Garcia; Thibaut Douche; Olivier Gorgette; Pascal Courtin; Sandrine Denis-Quanquin; Sandra Hoys; Yannick D N Tremblay; Mariette Matondo; Marie-Pierre Chapot-Chartier; Claire Janoir; Bruno Dupuy; Thomas Candela; Isabelle Martin-Verstraete
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

7.  Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.

Authors:  Jenessa A Winston; Alissa J Rivera; Jingwei Cai; Rajani Thanissery; Stephanie A Montgomery; Andrew D Patterson; Casey M Theriot
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

8.  Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.

Authors:  Casey M Theriot; Alison A Bowman; Vincent B Young
Journal:  mSphere       Date:  2016-01-06       Impact factor: 4.389
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.